Activities per year
Activities
Search results
-
Arrest of the Reversal Phase in Postmenopausal and Glucocorticoid-Induced Osteoporosis
Pia Rosgaard Jensen (Lecturer)
19. Sep 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Increased Density of Capillaries and Dividing Cells at Remodeling Sites in Adult Human Bone
Helene Bjørg Kristensen (Lecturer)
19. Sep 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Bone remodeling compartments in humans
Thomas Levin Andersen (Lecturer)
16. Sep 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Bone remodeling: How are bone resorption and formation integrated in a joint bone renewal program?
Jean-Marie Delaissé (Lecturer)
27. Jun 2011 → 29. Jun 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Are reversal cells critical players in the bone loss occurring in postmenopausal osteoporosis?
Thomas Levin Andersen (Lecturer)
28. Apr 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Arrest of the reversal phase is a critical mechanism invovled in Glucocorticoid-induced bone loss
Pia Rosgaard Jensen (Lecturer)
28. Apr 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Does treatment of multiple myeloma with a combination of bortezomib and dexamethasone result in opposite effects on osteoclasts and osteoclast precursors?
Ragad Hamid (Lecturer)
28. Apr 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Increased frequency of capillaries at remodeling sites in Adult Human Bone
Helene Bjørg Kristensen (Lecturer)
28. Apr 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Mechanisms controlling the direction and termination of osteoclastic resorption
Ditte Marie Horslev Merrild (Lecturer)
28. Apr 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Phenotypic characterization of the mononucleated cells appearing during the reversal phase of bone remodelling
Mohamed Essameldim Abdelgawad (Lecturer)
28. Apr 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Øget frekvens af kapillærer ved human knogle remodelering
Helene Bjørg Kristensen (Lecturer)
4. Mar 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Hæmatologi for bioanalytikere
Helene Bjørg Kristensen (Lecturer)
9. Feb 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Biophosphonat behandling ved myelomatose
Thomas Lund (Lecturer)
16. Sep 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Hvad går galt i postmenopausal osteoporose?
Thomas Levin Andersen (Lecturer)
16. Sep 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Bone remodeling compartments
Thomas Levin Andersen (Lecturer)
31. Aug 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Individual patient tailored bisphophonate treatment
Thomas Lund (Lecturer)
31. Aug 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Information and up-date on CZOL446EDK01T
Kent Søe (Lecturer)
31. Aug 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Overview and perspectives
Jean-Marie Delaissé (Lecturer)
31. Aug 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Bone remodeling: how are bone resorption and formation integrated in a joint bone renewal program?
Jean-Marie Delaissé (Lecturer)
15. Jun 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
The bone remodeling compartment in adult bone remodelling
Thomas Levin Andersen (Lecturer)
3. Jun 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
"Absence of bone remodeling compartment canopies correlates with deficient bone formation in post-menopausal women".
Thomas Levin Andersen (Lecturer)
29. Apr 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
"Osteoclast fusion"
Anne-Sofie Hobolt-Pedersen (Lecturer)
29. Apr 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Absence of bone remodeling compartment canopies correlates with deficient bone formation in post-menopausal women.
Thomas Levin Andersen (Lecturer)
19. Mar 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
"Introduction to the Research at the Clinical Cell Biology Department of Sygehus Lillebælt".
Jean-Marie Delaissé (Lecturer)
14. Jan 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
"The bone remodeling compartment is a key player in coupled bone remodeling".
Thomas Levin Andersen (Lecturer)
14. Jan 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
New insights in the patho-physiology and management of osteolytic bone disease in multiple myeloma
Torben Plesner (Speaker)
1. Dec 2009Activity: Talks and presentations › Talks and presentations in private or public companies
-
New insights in the patho-physiology and management of osteolytic bone disease in multiple myeloma
Jean-Marie Delaissé (Speaker)
1. Dec 2009Activity: Talks and presentations › Talks and presentations in private or public companies
-
Osteoclast fusion
Anne-Sofie Hobolt-Pedersen (Speaker)
12. Nov 2009Activity: Talks and presentations › Talks and presentations in private or public companies
-
Cell fusion in multiple myeloma
Jean-Marie Delaissé (Speaker)
8. Oct 2009 → 11. Oct 2009Activity: Talks and presentations › Talks and presentations in private or public companies
-
Rapid stimulation of bone formation by bortezomib in multiple myeloma
Thomas Lund (Speaker)
6. Oct 2009Activity: Talks and presentations › Talks and presentations in private or public companies